Shuttle Pharmaceuticals Holdings (SHPH) Depreciation & Amortization (CF) (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Depreciation & Amortization (CF) of $633340.0 for Q1 2026, up 62731.35% year-over-year from N/an in Q1 2025, and up 62731.35% quarter-over-quarter from $1008.0 in Q3 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $633340.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 62731.35% year-over-year to $633340.0; the TTM figure through Mar 2026 stood at $633369.0 (up 13792.72% YoY), while the FY2025 annual figure was $290107.0, up 5210.4% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $633340.0, up from $1008.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $633340.0 in Q1 2026, with the low at -$979.0 in Q2 2025.
- The 5-year median for Depreciation & Amortization (CF) is $1485.0 (2022), against an average of $40788.9.
- The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) slumped 201.77% in 2025, then jumped 62731.35% in 2026.
- Shuttle Pharmaceuticals Holdings' Depreciation & Amortization (CF) stood at $1488.0 in 2022, then soared by 33.27% to $1983.0 in 2023, then declined by 9.43% to $1796.0 in 2024, then sank by 43.88% to $1008.0 in 2025, then surged by 62731.35% to $633340.0 in 2026.
- Business Quant data shows SHPH's Depreciation & Amortization (CF) at $633340.0 in Q1 2026, $1008.0 in Q3 2025, and -$979.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | 633,340.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 633,340.00 |
| Mar 31, 2026 | 633,340.00 |
| Sep 30, 2025 | 1,008.00 |
| Sep 30, 2025 | 1,008.00 |
| Jun 30, 2025 | -979.00 |
| Jun 30, 2025 | -979.00 |
| Mar 31, 2025 | 1,008.00 |
| Mar 31, 2025 | 1,008.00 |
| Dec 31, 2024 | 1,796.00 |
| Dec 31, 2024 | 1,796.00 |
| Sep 30, 2024 | 793.00 |
| Sep 30, 2024 | 793.00 |
| Jun 30, 2024 | 962.00 |
| Jun 30, 2024 | 962.00 |
| Mar 31, 2024 | 1,912.00 |
| Mar 31, 2024 | 1,912.00 |
| Dec 31, 2023 | 1,983.00 |
| Dec 31, 2023 | 1,983.00 |
| Sep 30, 2023 | 1,858.00 |
| Sep 30, 2023 | 1,858.00 |